Point72 Hong Kong Ltd - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$65,000
-69.3%
950
-77.3%
0.00%
-71.4%
Q1 2022$212,000
+488.9%
4,181
+449.4%
0.01%
+600.0%
Q4 2021$36,000
-87.8%
761
-91.5%
0.00%
-90.0%
Q3 2021$296,000
-22.7%
8,979
+48.2%
0.01%
-16.7%
Q2 2021$383,000
+2846.2%
6,057
+1289.2%
0.01%
+1100.0%
Q3 2020$13,000
-69.8%
436
-67.2%
0.00%
-80.0%
Q2 2020$43,000
+43.3%
1,330
+19.2%
0.01%
-61.5%
Q1 2020$30,000
+2900.0%
1,116
+2690.0%
0.01%
Q3 2019$1,000
-66.7%
40
-70.8%
0.00%
-100.0%
Q1 2019$3,0000.0%137
-41.9%
0.00%0.0%
Q4 2018$3,0002360.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders